Frontage Holdings Corporation

US
FGHQF
paper.types.company
Rentabilité sur six mois: +0%
Rendement en dividendes: 0%

0.101 $

0 $ +0%
0.101 $
0.12 $

paper.min_max_per_year

Calendrier des promotions Frontage Holdings Corporation

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Frontage Holdings Corporation

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services.

plus de détails
The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 0.8049 9
P/BV 0.6138 10
P/E 259.38 1
Efficacité
Nom Signification Grade
ROA 0.1406 1
ROE 0.2342 1
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 3.09 4
Debt/Ratio 0.2788 10
Debt/Equity 0.6561 9
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 102.56 10
Rentabilité Ebitda, % 78.22 8
Rentabilité EPS, % -95.81 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 0.101 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 0.101 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 0.101 $ 0.101 $ 0.101 $ 0 % 0 % 0 %
common.calendar.number_days.90d 0.101 $ 0.101 $ 0.101 $ 0 % 0 % 0 %
common.calendar.number_days.180d 0.101 $ 0.101 $ 0.101 $ 0 % 0 % 0 %
common.calendar.number_days.1y 0.162 $ 0.101 $ 0.12 $ -37.65 % 0 % 0 %
common.calendar.number_days.3y 0.6199 $ 0.101 $ 0.6199 $ -83.71 % 0 % 0 %
common.calendar.number_days.5y 0 $ 0.101 $ 0.8 $ 0 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.101 $ 0.8 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 0.101 $ 0.101 $ 0.101 $ 0 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Song Li Ph.D. Founder & Chairman 1957 (68 années)
Dr. Abdul Ezaz Mutlib Ph.D. Chief Executive Officer 1961 (64 année)
Mr. Jun Gao CFO & President of Asia Pacific 1976 (49 années)
Mr. Richard Fischetti J.D. VP & General Counsel of Frontage Labs 1983 (42 année)
Dr. Dongmei Wang Ph.D. Executive Vice President of Global Sales & Marketing and Project Management 1964 (61 année)
Dr. Zhongping Lin Ph.D. President of Frontage Labs 1964 (61 année)
Dr. Tianyi Zhang Senior VP of the Group & GM of Frontage Shanghai 1969 (56 années)
Mr. Sudendra Rao Ph.D. Senior Vice President of Human Resources - North America
Dr. Wentao Zhang Ph.D. Chief Strategy Officer at Frontage Laboratories
Dr. John Kapeghian Ph.D. Executive Vice President of Global Safety & Toxicology

Informations sur l'entreprise

Adresse: United States, Exton, 700 Pennsylvania Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.frontagelab.com